These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 8062042)

  • 21. Prevention of vascularized allograft and xenograft rejection in rodents by brequinar sodium.
    Cramer DV; Chapman FA; Makowka L
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):23-8. PubMed ID: 8516938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxicology and adverse effects of drugs used for immunosuppression in organ transplantation.
    Philip AT; Gerson B
    Clin Lab Med; 1998 Dec; 18(4):755-65. PubMed ID: 9891613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transplantation immunology: what the clinician needs to know for immunotherapy.
    Rosen HR
    Gastroenterology; 2008 May; 134(6):1789-801. PubMed ID: 18471555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic assays for rejection and tolerance in organ transplantation.
    Bradley BA
    Transpl Immunol; 2005 Aug; 14(3-4):193-201. PubMed ID: 15982563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunosuppression regimens to address alloantibodies in transplant recipients.
    Everly MJ
    Clin Transpl; 2012; ():219-23. PubMed ID: 23721025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Has effective immunosuppression eliminated the need for transplant immunology?
    Calne R
    Transplant Proc; 1992 Dec; 24(6):2366-8. PubMed ID: 1465798
    [No Abstract]   [Full Text] [Related]  

  • 27. [The immunogenicity of different organs and the characteristics of immunosuppressive therapy during their allotransplantation].
    Kiprenskiĭ IuV; Erofeev GP
    Khirurgiia (Mosk); 1992 Mar; (3):123-32. PubMed ID: 1434354
    [No Abstract]   [Full Text] [Related]  

  • 28. Chronic allograft dysfunction: mechanisms and new approaches to therapy.
    Womer KL; Vella JP; Sayegh MH
    Semin Nephrol; 2000 Mar; 20(2):126-47. PubMed ID: 10746856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolving immunosuppressive regimens for lung transplant recipients.
    Meyer NJ; Bhorade SM
    Semin Respir Crit Care Med; 2006 Oct; 27(5):470-9. PubMed ID: 17072795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Individuality: the barrier to optimal immunosuppression.
    Kahan BD
    Nat Rev Immunol; 2003 Oct; 3(10):831-8. PubMed ID: 14523389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal.
    Mehra MR; Ventura HO; Chambers RB; Ramireddy K; Smart FW; Stapleton DD
    J Heart Lung Transplant; 1997 Jul; 16(7):743-51. PubMed ID: 9257256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How can we measure immunologic tolerance in humans?
    Najafian N; Albin MJ; Newell KA
    J Am Soc Nephrol; 2006 Oct; 17(10):2652-63. PubMed ID: 16928808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review of transplantation--1999.
    Hirose R; Vincenti F
    Clin Transpl; 1999; ():295-315. PubMed ID: 11038649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunosuppression and tumor development in organ transplant recipients: the emerging dualistic role of rapamycin.
    Gaumann A; Schlitt HJ; Geissler EK
    Transpl Int; 2008 Mar; 21(3):207-17. PubMed ID: 18069922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunosuppression in transplantation. A new millennium in care.
    Poole P; Greer E
    Crit Care Nurs Clin North Am; 2000 Sep; 12(3):315-21. PubMed ID: 11855236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversal of accelerated renal allograft rejection with FK 506.
    Woodle ES; Newell KA; Haas M; Bartosh S; Josephson MA; Millis JM; Bruce DS; Piper JB; Aronson AJ; Thistlethwaite JR
    Clin Transplant; 1997 Aug; 11(4):251-4. PubMed ID: 9267710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal transplantation, past, present and future.
    Ponticelli C; Tarantino A; Vegeto A
    J Nephrol; 1999; 12 Suppl 2():S105-10. PubMed ID: 10688409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunosuppression in pediatric solid organ transplantation.
    Agarwal A; Pescovitz MD
    Semin Pediatr Surg; 2006 Aug; 15(3):142-52. PubMed ID: 16818135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sirolimus: mammalian target of rapamycin inhibitor to prevent kidney rejection.
    Cowan PA; Heizer KE
    Nephrol Nurs J; 2000 Dec; 27(6):623-5. PubMed ID: 16649344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Steroid-free immunosuppression in organ transplantation.
    Luo G; Falta EM; Elster EA
    Curr Diab Rep; 2005 Aug; 5(4):305-10. PubMed ID: 16033684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.